1. Home
  2. NTST vs NRIX Comparison

NTST vs NRIX Comparison

Compare NTST & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.35

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$17.72

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
NRIX
Founded
2019
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NTST
NRIX
Price
$20.35
$17.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
12
Target Price
$22.02
$30.50
AVG Volume (30 Days)
1.1M
2.3M
Earning Date
04-20-2026
04-08-2026
Dividend Yield
4.28%
N/A
EPS Growth
150.00
N/A
EPS
0.06
N/A
Revenue
$195,006,000.00
$76,987,000.00
Revenue This Year
$19.03
N/A
Revenue Next Year
$16.25
$48.05
P/E Ratio
$336.33
N/A
Revenue Growth
19.79
99.31
52 Week Low
$16.14
$8.20
52 Week High
$21.30
$22.50

Technical Indicators

Market Signals
Indicator
NTST
NRIX
Relative Strength Index (RSI) 52.99 60.48
Support Level $20.11 $16.81
Resistance Level $21.13 $19.98
Average True Range (ATR) 0.40 1.26
MACD 0.03 0.06
Stochastic Oscillator 76.68 77.30

Price Performance

Historical Comparison
NTST
NRIX

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: